Childhood Malignant Mesenchymoma Completed Phase 1 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028728 (Childhood Malignant Mesenchymoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00720174Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaTreatment